通过下一代测序发现了新的HLA-DPA1*02:02:02:22等位基因
Panagiota Mantziou1, Theofilos Athanassiades1, Vasiliki Kitsiou1
1Immunology-Histocompatibility Department, Evangelismos General Hospital, Athens, Greece.
HLA
|May 9, 2025
概括
HLA-DPA1*02:02:02:22等位基因是HLA-DPA1基因的一个新发现的变异. 它与已知的等位基因有所不同,因其在intron 1中单个核酸替代.
科学领域:
- 免疫遗传学 免疫遗传学
- 分子生物学分子生物学
背景情况:
- 人类白细胞抗原 (HLA) 系统在免疫反应中起着至关重要的作用.
- HLA基因中的遗传变异,如HLA-DPA1,有助于免疫多样性和疾病易感性.
研究的目的:
- 为了表征HLA-DPA1基因的新型等位基因.
- 确定新型等位基因与已知相关等位基因之间的特定遗传差异.
主要方法:
- 使用了高分辨率的HLA排版技术.
- 进行DNA测序以分析等位基因的遗传构成.
主要成果:
- 一个新的等位基因被确定,被指定为HLA-DPA1*02:02:02:22.
- 这种新型的等位基因与HLA-DPA1*02:02:02:01的区别在于位于内子1的单个核酸替代.
结论:
- 鉴定HLA-DPA1*02:02:02:22扩大了已知的HLA-DPA1基因的等位基因多样性.
- 了解这些变异对于准确的HLA类型和免疫学研究至关重要.
关键词:
HLA-DPA1*02:02:02:22:22 HLA-DPA1*02:02:02:22:22 HLA-DPA1*02:02:02:22:22 HLA-DPA1*02:02:02:22 HLA-DPA1*02:02:02:22 HLA-DPA1*02:02:02:22 HLA-DPA1*02:02:02:22 HLA-DPA1*02:02:02:22 HLA-DPA1*02:02:02:22 HLA-DPA1*02:02:02:22 HLA-DPA1*02:02:02:22 HLA-DPA1*02:02:02:02:22 HLA-DPA1*02:02:02:22 HLA-DPA1*02:02:02:22 HLA-DPA1*02:02:02:02:22 HLA-DPA1*02:02:02:02:22 HLA-DPA1*02:02:02:02:22 HLA-DPA1*0通过HLA基因型鉴定进行HLA基因型鉴定.这就是Illumina Illumina.下一代测序的下一代测序.一个新型的等位基因更多相关视频
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
12.9K
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
11.7K
相关概念视频
Genome-wide Association Studies-GWAS
12.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.2K
Single Nucleotide Polymorphisms-SNPs
13.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.7K
Next-generation Sequencing
86.3K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
86.3K
